Join our panel of FDA and Life Sciences experts (including special guest former FDA Principal Deputy Commissioner Dr. Namandjé Bumpus) as we provide an overview of the FDA CDER, CDHR, and CBER approval of clinical investigations and marketing approval of new products for TTOs. Understand the process and explore options for taking your innovations from the lab into the hands of patients and physicians, as our experts guide you through the FDA approval pathways for drugs, medical devices, and biologics followed by expert panel advice and discussion regarding strategies, best practices, possible risks and challenges, and more.